Dermatol. praxi. 2009;3(1):34-36

Postherpetic neuralgia and its therapy

MUDr. Robert Opavský
Neurologické oddělení, Nemocnice Šternberk

Postherpetic neuralgia is a painful syndrome affecting approximately 20 % of herpes zoster patients. The neuropathic pain, a dominant

symptom of this syndrome, has a significant negative impact on quality of life. Prompt initiation of antiviral therapy in acute herpes

zoster is a key preventative measure in the management of postherpetic neuralgia. Tricyclic antidepressants, modern antiepileptic drugs

and opioids have the most important role in the symptomatic therapy.

Keywords: postherpetic neuralgia, herpes zoster, neuropathic pain, gabapentin, acyclovir.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Opavský R. Postherpetic neuralgia and its therapy. Dermatol. praxi. 2009;3(1):34-36.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Niv D, Maltsman-Tseikhin A. Postherpetic neuralgia: the never-ending challenge. Pain Pract 2005; 4: 327-340. Go to original source... Go to PubMed...
    2. Schmader K. Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med 2007; 3: 615-632. Go to original source... Go to PubMed...
    3. Christo PJ, Hobelmann G, Maine DN. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs Aging 2007; 1: 1-19. Go to original source... Go to PubMed...
    4. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1): S1-26. Go to original source... Go to PubMed...
    5. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. Mar 1994; 13: 896-900. Go to original source... Go to PubMed...
    6. Holcomb K, Weinberg JM. A novel vaccine (Zostavax) to prevent herpes zoster. G Ital Dermatol Venereol 2008; 2: 119-123.
    7. Zin CS, Nissen LM, Smith MT, O'Callaghan JP, Moore BJ. An update on the pharmacological management of postherpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008; 5: 417-442. Go to original source... Go to PubMed...
    8. Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 4: 287-313. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.